TCI Co., Ltd. (8436.TWO)
- Previous Close
144.00 - Open
143.00 - Bid 145.00 x --
- Ask 145.50 x --
- Day's Range
143.00 - 146.00 - 52 Week Range
138.50 - 215.50 - Volume
115,303 - Avg. Volume
471,018 - Market Cap (intraday)
16.761B - Beta (5Y Monthly) 0.63
- PE Ratio (TTM)
18.95 - EPS (TTM)
7.68 - Earnings Date May 6, 2024 - May 10, 2024
- Forward Dividend & Yield 5.02 (3.49%)
- Ex-Dividend Date Jul 27, 2023
- 1y Target Est
144.25
TCI Co., Ltd., an original design manufacturer company, engages in the research, development, manufactures, and sales of functional health food, supplements, and personal care products. It offers liquid and solid supplements; immunity products; functional probiotics; basic nutrition; detox slimming; body health; sports nutrition supplements product; laundry detergents; hand sanitizers; and functional snacks, which includes, jelly, bars, chocolates, and gummies. It also provides skin care products, such as facial, body sheet, eye, and lip masks; essences; functional sprays; creams; and gels, as well as turnkey services. TCI Co., Ltd. was incorporated in 1980 and is headquartered in Taipei, Taiwan.
www.tci-bio.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: 8436.TWO
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 8436.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 8436.TWO
Valuation Measures
Market Cap
16.59B
Enterprise Value
12.40B
Trailing P/E
18.75
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.10
Price/Book (mrq)
2.02
Enterprise Value/Revenue
1.55
Enterprise Value/EBITDA
6.66
Financial Highlights
Profitability and Income Statement
Profit Margin
11.18%
Return on Assets (ttm)
4.51%
Return on Equity (ttm)
9.94%
Revenue (ttm)
8.02B
Net Income Avi to Common (ttm)
896.26M
Diluted EPS (ttm)
7.68
Balance Sheet and Cash Flow
Total Cash (mrq)
5.65B
Total Debt/Equity (mrq)
14.86%
Levered Free Cash Flow (ttm)
1.21B
Research Analysis: 8436.TWO
Company Insights: 8436.TWO
8436.TWO does not have Company Insights